Clopidogrel bisulfate tablets can play a role in antiplatelet aggregation, for the prevention of atherosclerosis thrombosis, the treatment of atrial fibrillation and so on. Clopidogrel bisulfate tablets are adenosine diphosphate receptor antagonist drugs, which can play a role in inhibiting platelet aggregation, thus playing a role in preventing and treating diseases. Clinically, it can be used to prevent atherosclerotic thrombosis and thrombosis after coronary artery bypass grafting, and can also be used in patients with symptomatic carotid artery stenosis and atrial fibrillation. It should be noted that the drug is contraindicated in people who are allergic to clopidogrel bisulfate tablets or other components of the drug, active bleeding, severe liver damage, and a history of transient ischemic attacks; adverse reactions such as rash, abdominal pain, diarrhea, indigestion, and bleeding may occur after the use of the drug. Patients who need to use clopidogrel bisulfate tablets for treatment are recommended to use the drug under the guidance of a doctor.